Cargando…
Therapeutic Antibodies in Medicine
Antibody engineering has developed into a wide-reaching field, impacting a multitude of industries, most notably healthcare and diagnostics. The seminal work on developing the first monoclonal antibody four decades ago has witnessed exponential growth in the last 10–15 years, where regulators have a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535987/ https://www.ncbi.nlm.nih.gov/pubmed/37764213 http://dx.doi.org/10.3390/molecules28186438 |
_version_ | 1785112759770284032 |
---|---|
author | Sharma, Prerna Joshi, Rahul V. Pritchard, Robert Xu, Kevin Eicher, Maya A. |
author_facet | Sharma, Prerna Joshi, Rahul V. Pritchard, Robert Xu, Kevin Eicher, Maya A. |
author_sort | Sharma, Prerna |
collection | PubMed |
description | Antibody engineering has developed into a wide-reaching field, impacting a multitude of industries, most notably healthcare and diagnostics. The seminal work on developing the first monoclonal antibody four decades ago has witnessed exponential growth in the last 10–15 years, where regulators have approved monoclonal antibodies as therapeutics and for several diagnostic applications, including the remarkable attention it garnered during the pandemic. In recent years, antibodies have become the fastest-growing class of biological drugs approved for the treatment of a wide range of diseases, from cancer to autoimmune conditions. This review discusses the field of therapeutic antibodies as it stands today. It summarizes and outlines the clinical relevance and application of therapeutic antibodies in treating a landscape of diseases in different disciplines of medicine. It discusses the nomenclature, various approaches to antibody therapies, and the evolution of antibody therapeutics. It also discusses the risk profile and adverse immune reactions associated with the antibodies and sheds light on future applications and perspectives in antibody drug discovery. |
format | Online Article Text |
id | pubmed-10535987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105359872023-09-29 Therapeutic Antibodies in Medicine Sharma, Prerna Joshi, Rahul V. Pritchard, Robert Xu, Kevin Eicher, Maya A. Molecules Review Antibody engineering has developed into a wide-reaching field, impacting a multitude of industries, most notably healthcare and diagnostics. The seminal work on developing the first monoclonal antibody four decades ago has witnessed exponential growth in the last 10–15 years, where regulators have approved monoclonal antibodies as therapeutics and for several diagnostic applications, including the remarkable attention it garnered during the pandemic. In recent years, antibodies have become the fastest-growing class of biological drugs approved for the treatment of a wide range of diseases, from cancer to autoimmune conditions. This review discusses the field of therapeutic antibodies as it stands today. It summarizes and outlines the clinical relevance and application of therapeutic antibodies in treating a landscape of diseases in different disciplines of medicine. It discusses the nomenclature, various approaches to antibody therapies, and the evolution of antibody therapeutics. It also discusses the risk profile and adverse immune reactions associated with the antibodies and sheds light on future applications and perspectives in antibody drug discovery. MDPI 2023-09-05 /pmc/articles/PMC10535987/ /pubmed/37764213 http://dx.doi.org/10.3390/molecules28186438 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sharma, Prerna Joshi, Rahul V. Pritchard, Robert Xu, Kevin Eicher, Maya A. Therapeutic Antibodies in Medicine |
title | Therapeutic Antibodies in Medicine |
title_full | Therapeutic Antibodies in Medicine |
title_fullStr | Therapeutic Antibodies in Medicine |
title_full_unstemmed | Therapeutic Antibodies in Medicine |
title_short | Therapeutic Antibodies in Medicine |
title_sort | therapeutic antibodies in medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535987/ https://www.ncbi.nlm.nih.gov/pubmed/37764213 http://dx.doi.org/10.3390/molecules28186438 |
work_keys_str_mv | AT sharmaprerna therapeuticantibodiesinmedicine AT joshirahulv therapeuticantibodiesinmedicine AT pritchardrobert therapeuticantibodiesinmedicine AT xukevin therapeuticantibodiesinmedicine AT eichermayaa therapeuticantibodiesinmedicine |